NO20051461L - lnhaleringssammensetning - Google Patents

lnhaleringssammensetning

Info

Publication number
NO20051461L
NO20051461L NO20051461A NO20051461A NO20051461L NO 20051461 L NO20051461 L NO 20051461L NO 20051461 A NO20051461 A NO 20051461A NO 20051461 A NO20051461 A NO 20051461A NO 20051461 L NO20051461 L NO 20051461L
Authority
NO
Norway
Prior art keywords
microns
diameter
less
lactose particles
mixture
Prior art date
Application number
NO20051461A
Other languages
English (en)
Norwegian (no)
Inventor
Xian-Ming Zeng
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9942746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051461(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of NO20051461L publication Critical patent/NO20051461L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20051461A 2002-08-21 2005-03-18 lnhaleringssammensetning NO20051461L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219513A GB0219513D0 (en) 2002-08-21 2002-08-21 Inhalation compositions including coarse carrier
PCT/US2003/026385 WO2004017914A2 (en) 2002-08-21 2003-08-21 Inhalation composition

Publications (1)

Publication Number Publication Date
NO20051461L true NO20051461L (no) 2005-05-20

Family

ID=9942746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051461A NO20051461L (no) 2002-08-21 2005-03-18 lnhaleringssammensetning

Country Status (8)

Country Link
BR (1) BRPI0313647A2 (pt)
CA (1) CA2499273C (pt)
ES (1) ES2371601T3 (pt)
GB (1) GB0219513D0 (pt)
NO (1) NO20051461L (pt)
TN (1) TNSN05047A1 (pt)
WO (1) WO2004017914A2 (pt)
ZA (1) ZA200502177B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
PL2708225T3 (pl) 2004-04-23 2019-07-31 Cydex Pharmaceuticals, Inc. Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
RU2007133547A (ru) * 2005-02-10 2009-03-20 Глаксо Груп Лимитед (GB) Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
GB0605723D0 (en) 2006-03-23 2006-05-03 3M Innovative Properties Co Powder filling processes
WO2008134817A1 (en) * 2007-05-03 2008-11-13 The University Of Sydney Composite carriers for dry powder inhalation therapy
TR201105367A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR201205852A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Geliştirilmiş yeni kuru toz formülasyonu.
UA115989C2 (uk) 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
NZ703866A (en) 2012-07-19 2016-05-27 Adamis Pharmaceuticals Corp Powder feeding apparatus
JP6251667B2 (ja) 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
DE69818872T2 (de) * 1998-12-11 2004-05-19 Pharmachemie B.V. Pharmazeutische zubereitungen zur inhalation eines opioids
PL200063B1 (pl) 2000-10-12 2008-12-31 Boehringer Ingelheim Pharma Nowe proszki do inhalacji zawierające tiotropium
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling

Also Published As

Publication number Publication date
WO2004017914A3 (en) 2004-04-29
ES2371601T3 (es) 2012-01-05
GB0219513D0 (en) 2002-10-02
WO2004017914A2 (en) 2004-03-04
TNSN05047A1 (en) 2007-05-14
CA2499273C (en) 2011-06-21
ZA200502177B (en) 2006-05-31
WO2004017914A8 (en) 2005-07-07
BRPI0313647A2 (pt) 2019-02-19
CA2499273A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
TNSN07195A1 (en) Potentiators of glutamate receptors
PL1713446T3 (pl) Nielamelarne trójskładnikowe kompozycje lipidów
EA200501363A1 (ru) Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
NO20062798L (no) Anvendelse av en vannholdig dispersjon av i det minste en bio-nedbrytbar polymer inneholdende i det minste et stabiliseringsmiddel for fremstilling av en vanndig filmdannende sammensetning
AU2002241723A1 (en) Storage stable powder compositions of interleukin-4 receptor
HUP0400252A2 (hu) MCH modulátor hatású aril- és biaril-vegyületek, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
GEP20074125B (en) Pyrazolopyridines and methods of making and using the same
WO2005032464A3 (en) Phenyl pyrrolidine ether tachykinin receptor antagonists
ATE520405T1 (de) Inhalationszusammensetzung
TNSN05047A1 (en) Inhalation composition
SI1539114T1 (sl) Filmska obloga za tablete in kaplete
NO20072005L (no) Nye heterocykliske amider
WO2008147812A3 (en) 4' substituted compounds having 5-ht6 receptor affinity
WO2005017170A3 (en) Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
GB0223724D0 (en) Refrigerant compositions
UA86056C2 (ru) Твердый дисперсионный состав базедоксифена ацетата, способ его получения (варианты) и применение (варианты)
TW200621752A (en) Pyrimidinylpyrazoles and methods of making and using the same
WO2007073303A3 (en) Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors
NO20044803L (no) Dobbeltherdende emulsjoner
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
UA95922C2 (en) Glucuronate salt of a piperazine compound
WO2005097087A3 (en) Merged ion channel modulating compounds and uses thereof
MXPA04000106A (es) Composiciones acuosas que comprenden un microgel quimico asociados con un polimero acuoso.
WO2005090287A3 (en) Phenylethanolamine derivatives as beta-2 agonists
WO2005042717A3 (en) Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application